Stay updated on Cabozantinib for CNS Tumors in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.

Latest updates to the Cabozantinib for CNS Tumors in Children Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page shows a new Revision: v3.4.2 and removes the previous Revision: v3.4.1 funding-operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedSite-wide notice informs users about a lapse in government funding and ongoing NIH operations; the site version updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThese updates are minor UI and metadata changes (Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0) and do not modify core study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision label updated in the page footer from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedLocations now include Indiana as the study site (Indianapolis, Riley Hospital for Children at IU Health). The previous Indiana Locations item and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib for CNS Tumors in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.